Logo image of AHI

ADVANCED HEALTH INTELLIGENCE (AHI) Stock Fundamental Analysis

NASDAQ:AHI - US00777C2035 - ADR

1.5 USD
-0.04 (-2.55%)
Last: 1/31/2024, 8:00:00 PM
1.5 USD
0 (0%)
After Hours: 1/24/2024, 8:11:37 PM
Fundamental Rating

0

Overall AHI gets a fundamental rating of 0 out of 10. We evaluated AHI against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of AHI have multiple concerns. AHI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AHI had negative earnings in the past year.
AHI had a negative operating cash flow in the past year.
AHI had negative earnings in each of the past 5 years.
AHI had a negative operating cash flow in each of the past 5 years.
AHI Yearly Net Income VS EBIT VS OCF VS FCFAHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

AHI's Return On Assets of -144.01% is on the low side compared to the rest of the industry. AHI is outperformed by 87.80% of its industry peers.
The Return On Equity of AHI (-632.54%) is worse than 75.61% of its industry peers.
Industry RankSector Rank
ROA -144.01%
ROE -632.54%
ROIC N/A
ROA(3y)-205.24%
ROA(5y)-192.79%
ROE(3y)-536.01%
ROE(5y)-713.75%
ROIC(3y)N/A
ROIC(5y)N/A
AHI Yearly ROA, ROE, ROICAHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -500 -1K -1.5K -2K

1.3 Margins

AHI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHI Yearly Profit, Operating, Gross MarginsAHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -1K -2K -3K

0

2. Health

2.1 Basic Checks

AHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AHI has more shares outstanding
The number of shares outstanding for AHI has been increased compared to 5 years ago.
The debt/assets ratio for AHI is higher compared to a year ago.
AHI Yearly Shares OutstandingAHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
AHI Yearly Total Debt VS Total AssetsAHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -13.96, we must say that AHI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AHI (-13.96) is worse than 85.37% of its industry peers.
A Debt/Equity ratio of 0.86 indicates that AHI is somewhat dependend on debt financing.
AHI's Debt to Equity ratio of 0.86 is on the low side compared to the rest of the industry. AHI is outperformed by 70.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Altman-Z -13.96
ROIC/WACCN/A
WACC11.03%
AHI Yearly LT Debt VS Equity VS FCFAHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.54 indicates that AHI may have some problems paying its short term obligations.
AHI has a Current ratio of 0.54. This is amonst the worse of the industry: AHI underperforms 82.93% of its industry peers.
A Quick Ratio of 0.54 indicates that AHI may have some problems paying its short term obligations.
AHI has a worse Quick ratio (0.54) than 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
AHI Yearly Current Assets VS Current LiabilitesAHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.80% over the past year.
Looking at the last year, AHI shows a very strong growth in Revenue. The Revenue has grown by 366.29%.
AHI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.04% yearly.
EPS 1Y (TTM)55.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.56%
Revenue 1Y (TTM)366.29%
Revenue growth 3Y61.12%
Revenue growth 5Y6.04%
Sales Q2Q%655.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AHI Yearly Revenue VS EstimatesAHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

0

4. Valuation

4.1 Price/Earnings Ratio

AHI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AHI Price Earnings VS Forward Price EarningsAHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AHI Per share dataAHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AHI!.
Industry RankSector Rank
Dividend Yield N/A

ADVANCED HEALTH INTELLIGENCE

NASDAQ:AHI (1/31/2024, 8:00:00 PM)

After market: 1.5 0 (0%)

1.5

-0.04 (-2.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2023-11-06
Earnings (Next)02-28 2024-02-28
Inst Owners0.03%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.66M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.42
P/FCF N/A
P/OCF N/A
P/B 8.83
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS0.23
BVpS0.17
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -144.01%
ROE -632.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-205.24%
ROA(5y)-192.79%
ROE(3y)-536.01%
ROE(5y)-713.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -13.96
F-Score4
WACC11.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)8.34%
Cap/Sales(5y)12.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)366.29%
Revenue growth 3Y61.12%
Revenue growth 5Y6.04%
Sales Q2Q%655.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.27%
OCF growth 3YN/A
OCF growth 5YN/A